Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients.
about
Microinjection of specific anti-IMPDH2 antibodies induces disassembly of cytoplasmic rods/rings that are primarily stationary and stable structuresAnti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapyLoukoumasomes Are Distinct Subcellular Structures from Rods and Rings and Are Structurally Associated with MAP2 and the Nuclear Envelope in Retinal CellsClinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection.Anti-rods/rings: a human model of drug-induced autoantibody generation.Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection.The Presence of Autoantibodies to Cytoplasmic Rod and Ring Particles in the Serum of Patients with Chronic Hepatitis C Virus Infection.Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis.From autoantibody research to standardized diagnostic assays in the management of human diseases - report of the 12th Dresden Symposium on Autoantibodies.Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015.Autoantibodies against "rods and rings"-related IMPDH2 in hepatitis C genotype 1 and DAA therapy in a "real life" cohort.Clinical correlates of the "rods and rings" antinuclear antibody pattern.Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients.Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.Anti-rods and rings autoantibodies in a patient with hepatitis C virus infection.Glutamine deprivation initiates reversible assembly of mammalian rods and rings.
P2860
Q22001144-86636A8A-E86B-4A90-B8F2-A0F8B1EEAB43Q26766115-BF990171-17D5-451C-B0A1-1BA29FB19407Q28553081-82F64633-6A68-4928-827B-082C90799569Q34626547-3B5C0C3A-772B-492F-ADC7-43D1541E636EQ35053443-66B9BDBF-5E65-44FF-B06E-2BB8B0C511A8Q37413335-2596817B-3BB7-493C-9784-E9A6D2A40825Q37587194-03993EBA-B934-41C9-8B6D-9A8A9B6470F3Q38497449-EBDDE408-E566-41AB-8CA0-DB926E296A71Q38851084-B29EB537-033A-459E-8739-9CF6A671E3C9Q38851088-F8C5CDC2-4910-4CA1-9164-3416B646535FQ40080572-B628E1B1-58FE-406C-AF67-469E24237335Q40176558-8D7799D6-EA1B-4D08-8B0E-68FE1539032DQ42205181-7C915FB4-C8F8-4773-84AC-283187F52DD4Q42214549-0721BB7E-E213-4F0E-BAF6-FDD5CF1C4F68Q43243275-5F9607FC-8CD7-4932-AB6F-2D9E604C9CDAQ45265983-01366E28-74B3-407F-B963-0FC2A2F8316E
P2860
Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Differential reactivity to IMP ...... n US and Italian HCV patients.
@en
Differential reactivity to IMP ...... n US and Italian HCV patients.
@nl
type
label
Differential reactivity to IMP ...... n US and Italian HCV patients.
@en
Differential reactivity to IMP ...... n US and Italian HCV patients.
@nl
prefLabel
Differential reactivity to IMP ...... n US and Italian HCV patients.
@en
Differential reactivity to IMP ...... n US and Italian HCV patients.
@nl
P2093
P2860
P1476
Differential reactivity to IMP ...... n US and Italian HCV patients.
@en
P2093
Claire Krueger
Danilo Villalta
Edward K L Chan
Massimo Daves
Minoru Satoh
S John Calise
Wendy C Carcamo
P2860
P2888
P304
P356
10.1007/S10875-012-9827-4
P577
2012-10-26T00:00:00Z